Risk-benefit point of the Model for End-stage Liver Disease score in patients waiting for deceased-donor liver transplantation: A single-center experience.
Sena IwamuraToshimi KaidoSatoshi MoritaYosuke MiyachiSiyuan YaoHisaya ShiraiAtsushi KobayashiYuhei HamaguchiNaoko KamoShintaro YagiShinji UemotoPublished in: Hepatology research : the official journal of the Japan Society of Hepatology (2019)
For all MELD categories, DDLT reduced the mortality risk of patients on the waiting list.